Following the return of spontaneous circulation after out-of-hospital cardiac arrest, neurological dysfunction, airway or ventilatory compromise can impede transport to early percutaneous coronary intervention, necessitating pre-hospital or emergency department anaesthesia to facilitate this procedure. There are no published reports of the ideal induction agents in these patients. We sought to describe haemodynamic changes associated with induction of anaesthesia using a midazolam (0.1 mg.kg ) and rocuronium (1 mg.kg À1 ) regimen developed using expert opinion, and adherence to the protocol by our pre-hospital teams. We performed a retrospective review of haemodynamic data recorded during induction of anaesthesia in patients following return of spontaneous circulation, over a 30-month period. We analysed the changes in systolic blood pressure and heart rate using a repeatedmeasures design, as well as the rate of new hypotension or hypertension. Sixty-four patients had four consecutive measurements for analysis (one pre-induction and three post-induction). Systolic blood pressure at all three post-induction measurements was significantly lower than the pre-induction value. Heart rate did not differ between any time-points. New episodes of hypotension (systolic pressure < 90 mmHg) occurred in four (6%) patients at the first measurement post-induction (95%CI 2-15%) and 10 (16%) at the third measurement (95%CI 8-27%). Three patients (5%; 95%CI 1-13%) had a hypertensive response. The median (IQR[range]) dose of midazolam given at induction was 0.04 (0.03-0.05 [0.01 to 0.10]) mg.kg
Introduction
Patients who achieve return of spontaneous circulation (ROSC) after out-of-hospital cardiac arrest (OHCA) may suffer from neurological dysfunction, ranging from delirium to seizures or unconsciousness [1] . When this occurs in pre-hospital patients, it can make transport to centres where percutaneous coronary intervention (PCI) can be undertaken difficult, especially if it makes the patient combative or impedes definitive airway management. Kent Surrey Sussex Air Ambulance Trust (KSSAAT) and Essex and Herts Air Ambulance Trust (EHAAT) offer an on-call service, whereby road paramedics can request a doctor and paramedic team who are able to perform pre-hospital rapid sequence induction (RSI) of anaesthesia, followed by ongoing sedation, to facilitate transport directly to PCI centres.
The period immediately following ROSC, however, may be associated with marked cardiovascular instability. Acute left ventricular impairment is common and can lead to hypotension, which itself is associated with increased mortality [1] [2] [3] [4] . Tachycardia is frequently reported, and may be due to endogenous or exogenous catecholamines [2] . The choice of RSI drugs should favour minimal alterations in haemodynamics. These include not inducing or exacerbating tachycardia, and attenuating the hypertensive response to intubation so as not to increase afterload, while also not predisposing to hypotension. There are no published reports on the ideal induction drug regimen to facilitate tracheal intubation immediately following ROSC after medical cardiac arrest. The current KSS and EHAAT post-ROSC RSI protocol comprises midazolam 0.1 mg.kg À1 , fentanyl 2 lg.kg À1 and rocuronium 1 mg.kg À1 , developed from expert opinion; it differs from our trauma protocol, which uses a ketamine-fentanyl-rocuronium combination.
We performed a retrospective chart review with to assess the haemodynamic changes around the time of intubation, as well as the rates of hypotension and hypertension that occurred using this combination of drugs. In addition, we wanted to measure adherence to our RSI protocol.
Methods
KSSAAT and EHAAT operate a physician-paramedic pre-hospital medical team to respond to severe trauma and acute medical conditions. Physicians comprise consultants, or registrars in their final year of training in anaesthesia, emergency medicine or intensive care. Drug doses for RSI are guided by a standard operating procedure; deviations are, however, allowed, provided they have been discussed and agreed between the paramedic and physician, or are advised by an on-call We extracted electronic vital signs data according to a standardised protocol using a Microsoft Excel spreadsheet (Redmond, WA, USA), where the RSI time was entered, and 3-min time periods automatically populated cells into which heart rate (HR) and systolic blood pressure (SBP) were to be extracted from the vital signs printouts. The data were then combined and anonymised.
The primary outcome measure was the pattern of change in heart rate (HR) and systolic blood pressure (SBP) for each 3-min interval, up to 9 min following induction of anaesthesia. Our secondary outcome measures were the proportion of patients experiencing new hypotension or hypertension at each 3-min interval, as well as adherence to the RSI protocol. Two definitions of hypotension were analysed separately, consistent with two different approaches used in previous studies [5] [6] [7] [8] . Firstly, a SBP > 90 mmHg before induction, with any new episode of SBP < 90 mmHg post-intubation; and secondly, a reduction in SBP, of more than 20% from baseline. Hypertension was defined as SBP < 160 mmHg pre-induction, with a SBP > 160 mmHg post-intubation.
We analysed our data using R statistical software (R Core Team: Vienna, version 3.2) and the PHIA (Post-Hoc Interaction Analysis) package [9] . The haemodynamic response was assessed using repeatedmeasures ANOVA, separately for SBP and then for HR. If sphericity assumptions were violated according to Mauchly tests, we applied the Greenhouse-Geisser correction. We calculated CI for effect sizes found by the repeated-measures ANOVA using the method described by Hollands and Jarmasz [10] .
We performed a power calculation for the haemodynamic data using Cohens method for ANOVA. To detect a medium effect size (0.5) with a power of 0.8 and significance level of 0.5, 12 participants per each repeated measure were needed, requiring a minimum of 48 participants.
Results
We initially identified 126 patients who underwent a midazolam-fentanyl-rocuronium RSI, of which 95 were for post-cardiac arrest ROSC; 64 of these patients had four consecutive vital signs for haemodynamic analysis (Fig. 1 ). Demographic and intubation data are provided in Table 1 . Most patients were men, and had suffered a cardiac arrest secondary to ventricular fibrillation (VF arrest). All patients had their tracheas successfully intubated, 93% at the first attempt. Of the 31 patients without haemodynamic data, one had a further cardiac arrest after RSI and was pronounced dead at the scene, while the remaining 30 were transported to hospital.
Drug-dose data are provided in Table 2 . One-fifth of patients received midazolam for sedation before RSI; however, the median total midazolam dose was similar to the median RSI-only midazolam dose. The SOP-recommended RSI midazolam dose of 0.1 mg.kg À1 was given to 13 patients (14%).
Sixty-seven patients had two pre-induction observations, that had been performed 3-min apart, available for analysis. The difference in mean SBP was 2 mmHg (95%CI -3 to 6, p = 0.50), indicating that SBP was not changing before induction of anaesthesia. The difference in mean HR was four beats per minute (95%CI -1 to 8, p = 0.11), indicating that HR was also stable pre-induction. All three post-induction SBPs were significantly lower than the pre-induction SBP. The third post-induction SBP was significantly lower than all other SBPs, whereas the second and first SBP post-induction (new line) were not different from each other (Tables 3 and 4 ; Fig. 2) . A new episode of hypotension, when defined as SBP less than 90 mmHg, was recorded in four patients (6%; 95%CI 2-15%) at the first SBP measurement, in six patients (10%; 95%CI 4-20%) at the second SBP, and in 10 patients (16%; 95%CI 8-27%) at the third SBP measurement. When hypotension was defined as a reduction in SBP greater than 20% below baseline, the pattern was different, with new episodes occurring in 12 patients at the first and second SBP measurement (19%; 95%CI 10-30%), and in eight patients at the third measurement (13%; 95%CI 6-23%). Only three patients (5%; 95%CI 1-13%) had a hypertensive response; two patients at the first measurement, and one at the second measurement. There were no significant differences in HR between any time period (p = 0.29) ( Table 3 , Fig. 2 ).
Discussion
We sought to investigate the haemodynamic changes in patients following return of spontaneous circulation, and drug doses chosen for patients who were intubated according to our midazolam-fentanyl-rocuronium RSI protocol. We found that the median dose of midazolam chosen by medical teams was 0.05 mg.kg
À1
. We also found that SBP decreased post-RSI, with the maximum difference from pre-RSI SBP occurring at the third post-RSI measurement. New hypotension was also more common for the third SBP measurement. Finally, the HR did not change post-RSI, and new episodes of hypertension were rare.
Although the minimal alterations in HR, and low rates of hypertension seen in our patients are desirable, the incidence of hypotension is of concern. As far as we GCS, Glasgow coma score; VF, ventricular fibrillation; AED, automatic defibrillator; PEA, pulseless electrical activity; VT, ventricular tachycardia; AF, atrial fibrillation. 
RSI, rapid sequence induction.
are aware, this is the first description of haemodynamic data immediately following RSI specifically in patients immediately following ROSC, and there are no studies with which to directly compare hypotension rates. Consequently, we have presented two definitions of hypotension to allow future comparisons with our results. The pattern of patients experiencing a SBP decrease of more than 20% appears consistent with the results of the ANOVA, in that there is a reduction in SBP postinduction that occurs with equal frequency at the first and second measurements. When hypotension is defined by a < 90 mmHg cut-off, it appears that some patients may experience a more gradual drop in SBP that presents as hypotension later. Larger doses of midazolam appear to be well tolerated in some patient groups. In a randomised, controlled trial of elective cardiac surgery patients with known left ventricular dysfunction, midazolam (0.15 mg.kg À1 ) with fentanyl (4 lg.kg
) was found to be the best induction agent at attenuating the hypertensive response to intubation, without changes in mean arterial pressure, when compared with either thiopentone, etomidate or propofol [11] . For emergency general surgery, midazolam (0.3 mg.kg
) without fentanyl was associated with no change in mean arterial pressure following induction of anaesthesia, when compared with ketamine-midazolam combinations, ketamine alone or thiopentone [12] . However, these patients may represent a more robust cohort, and are not representative of those in the acute stages Table 3 Systolic blood pressure and heart rate at each time of measurement. Values are mean (SD). RSI, rapid sequence induction. Table 4 Effect sizes for differences on mean systolic blood pressure (SBP) at each measurement. Values are mean (95%CI).
Comparison Difference in mean SBP p value
Pre-induction and 1st SBP post-RSI 11 (8) (9) (10) (11) (12) (13) (14) 0.006 Pre-induction and 2nd SBP post-RSI 14 (11) (12) (13) (14) (15) (16) (17) 0. ) without an opiate have been associated with more hypotension in trauma patients, when compared with a comparison group that had its maximum dose capped at 5 mg (21.7% vs. 6.7%) [13] . Similarly, in studies with mixed cohorts of medical and trauma patients, the hypotension rate (SBP < 90) with midazolam was 5.4% when 3.4 mg was used [14] , and 18% when 7 mg was used [15] . The cause of the hypotension in our patients could be multifactorial. It may be due to sympatholysis due to either the midazolam or fentanyl, in a group of patients who require sympathetic stimulation to maintain their SBP; or it may be due to the initiation of positive pressure ventilation, with a reduction in venous return impairing cardiac output [16] . In addition, one-third of our patients required adrenaline before RSI, indicative of the fragile cardiovascular state of these patients, and the hypotension observed may be due to the natural clinical course of their underlying cardiac condition.
Although the fentanyl and rocuronuim doses selected by medical teams were in accordance with our standard operating procedures, the median midazolam dose was half of the 0.1 mg.kg À1 advised. It is unclear why the medical teams chose a lower dose. In our patients, 75% received a dose of 5 mg or less. In addition, the total midazolam RSI dose was similar to the midazolam RSI-only dose, suggesting that when pre-RSI midazolam was given, the induction dose was adjusted to give a comparable overall amount. A similar deviation from a standard operating procedure suggesting midazolam 0.1 mg.kg À1 for trauma patients has been reported in another aeromedical organisation (average midazolam dose was 3.4 mg, with 85% receiving 5 mg or less) [14] . One reason proposed for these reduced doses was the familiarity with sedation doses by medical staff, leading them to use lower amounts of midazolam [14] . A concern with reducing the midazolam dose is the possibility of procedural awareness. Although doses of midazolam of 0.045 mg.kg À1 significantly reduced the incidence of awareness in patients undergoing elective surgery anaesthetised with propofol total intravenous anaesthetic [17] , and 75% of our patients had a GCS of 6 or less, sedated patients in intensive care have been reported to be at risk of awareness when undergoing general anaesthesia [18] .
We are not aware of any reports of awareness in patients following ROSC; however, a study investigating recall could be useful. This study is limited by being retrospective in nature. As it was not an interventional trail, we cannot comment on a dose-response relationship between midazolam or fentanyl and blood pressure changes, as it is possible that the dose of midazolam was reduced in patients in whom a hypotensive response was considered likely. Weight was estimated, not calculated; this, however, reflects real-life practice. We measured SBP and not mean arterial pressure, which may be a better marker of coronary perfusion; mean arterial pressure, however, is not currently recorded in our electronic database.
In our service with a midazolam (0.1 mg.kg
À1
), fentanyl (2 lg.kg À1 ) and rocuronium (1 mg.kg
) RSI protocol, physician-paramedic teams often reduced the midazolam dose to a median of 0.05 mg.kg
. The haemodynamic changes most commonly seen in our patients following ROSC were a reduction in SBP, with the largest differences occurring at the time of the third measurement, with little change in HR. To the best of our knowledge, these are the first data describing the haemodynamic changes in patients anaesthetised following ROSC using an RSI protocol; they will hopefully act as a comparator for other investigators looking to assess the best combination of induction agents in these patients.
